Skip to content
PatentBrief

Patent Prosecution

Office Actions Explained

Your application was rejected. That is completely normal — and it is not the end. Here is what an office action means, what the different rejection types say, and what you can do about it.

Educational guide only. Consult a registered patent attorney for your specific prosecution.

What is an office action?

An office action is an official written communication from a USPTO patent examiner. It comes during the examination of your patent application — typically 12–18 months after filing — and explains why your claims are being rejected or what formal objections exist.

A rejection is the rule, not the exception. Roughly 85–90% of all patent applications receive at least one office action before a patent issues. Many receive two or three. Getting an office action does not mean your invention is unpatentable — it usually means you need to either argue against the examiner's reasoning or amend your claims.

Non-final vs final office actions

A non-final office action opens prosecution. The examiner has reviewed your claims and made initial rejections or objections. You have a full opportunity to respond: amend your claims, argue against the rejections, or both.

A final office action comes after your first substantive response. 'Final' is a bit misleading — it doesn't end prosecution, but it limits your options. You can no longer freely amend claims (only amendments that place the application in condition for allowance, or that respond to new issues raised after the last office action, are typically entered). After a final, you typically must either accept the examiner's position, file a Request for Continued Examination (RCE), or appeal.

In practice: final rejections are often followed by an RCE, which reopens prosecution and starts the cycle again from a non-final posture.

The main rejection types

§ 102 Rejection — Anticipation

A single prior-art reference discloses every element of your claim. To overcome: distinguish your claim (argue the reference doesn't actually disclose element X), or amend the claim to add a limitation the reference lacks. Tip: read the reference carefully. Examiners sometimes misread or stretch a reference. If even one element of your claim isn't in the reference, you aren't anticipated.

§ 103 Rejection — Obviousness

The examiner is combining two or more references and arguing it would have been obvious to a skilled person to combine them and arrive at your invention. To overcome: argue there was no reason to combine those specific references; argue the combination would not yield your invention; cite evidence of unexpected results or secondary considerations (commercial success, long-felt need, failure of others). KSR (2007) made obviousness easier to argue, but unexpected results remain a powerful rebuttal.

§ 112 Rejection — Written Description / Enablement / Definiteness

Your specification doesn't adequately describe what you claimed (written description), doesn't enable a skilled person to make and use it (enablement), or your claim terms are too vague to define a clear scope (definiteness). To overcome: add clarifying language to the specification (may require a continuation-in-part if the matter is new), narrow the claims to what's actually described, or argue the term has a well-understood meaning in the field.

§ 101 Rejection — Patent Ineligible Subject Matter

Your claim covers an abstract idea, law of nature, or natural phenomenon without adding significantly more. Common in software and biotech. To overcome using the Alice/Mayo test: argue step 2B — identify a specific technical improvement your claims add beyond the abstract idea. Amendment strategy: add concrete, technical claim language that recites how the result is achieved, not just what result is achieved.

Restriction Requirement

Your application claims two or more independent and distinct inventions. Not a rejection — a requirement to elect one invention for examination now. The others can be pursued in divisional applications. Strategy: elect the broadest, most commercially important invention for the parent. File divisionals to pursue the others.

Deadlines — the most important dates

Non-final office action response deadline: 3 months from the mailing date without fee, extendable to 6 months with extension fees (which increase monthly). Extensions are one month at a time: the first extension costs around $200–500, subsequent months more.

Final office action response deadline: Same 3-month/6-month structure. But after a final, you must be more strategic. Use the full time.

Abandonment: Miss the 6-month deadline and the application is abandoned. You may be able to revive it within 2 months by petitioning and paying a fee — but this is an emergency procedure, not a routine option. Don't rely on it.

Advisory action: If you file an amendment after a final rejection and the examiner doesn't enter it, they issue an advisory action explaining why. If more than 3 months have passed since the final rejection date, you need to file a response (usually an RCE) quickly to preserve your rights.

Your response options

Argue (traverse) the rejection

Submit a written argument explaining why the examiner's rejection is wrong. No claim amendments — just argument. Best when the examiner misread the prior art or misapplied the law. Can be combined with claim amendments.

Amend the claims

Narrow or clarify the claims to distinguish the prior art. Adding a claim limitation that the prior art doesn't have can overcome a 102 or 103 rejection. Be careful: every limitation you add narrows the scope and may affect enforceability (prosecution history estoppel).

Interview the examiner

Request a telephonic or in-person interview with the examiner before filing a formal response. Examiners can often explain their reasoning informally and suggest what amendment would lead to allowance. Interviews frequently advance prosecution significantly. Highly recommended.

File a Request for Continued Examination (RCE)

After a final rejection, an RCE pays a fee and reopens prosecution. The application returns to a non-final posture. The same examiner examines the amended claims. RCEs are common but costly — they add time and money to prosecution. Sometimes the best choice, sometimes a sign of a drafting problem.

Appeal to the PTAB

File a notice of appeal to the Patent Trial and Appeal Board. The PTAB reviews the examiner's rejection de novo. Appeals take 1–2 years and cost $10,000–30,000+ in attorney fees, plus filing fees. Best when the examiner has made a legal error or misread the prior art and argument hasn't worked. Winning at the PTAB doesn't guarantee allowance — prosecution can continue after.

Continue to a continuation or divisional

If the broadest claims can't be allowed, abandon them and file a continuation with narrower, allowable claims. A continuation application must be filed while the parent is pending. You can maintain a family of applications with varying scope — broad claims pending on appeal while narrower claims are granted.

Strategic considerations

The examiner's citation of prior art in an office action is valuable even if you overcome the rejection. It tells you where the field is, what a competitor could point to to challenge your patent, and how to position claims in any continuations.

Don't just argue — also amend. The strongest responses both argue against the rejection AND amend the claims to more clearly distinguish the prior art. This creates a stronger prosecution record.

Every argument you make in a response can later be used against you in litigation (prosecution history estoppel). Be precise. Don't say 'our invention requires X' unless you mean every embodiment requires X.

Continuation strategy: file continuation applications before the parent issues if you want additional claim scope. Once the parent issues, you can still file continuations for the remaining pendency period — but once all family members issue or are abandoned, the family is closed.

Related

Office Action Response tool →Specification requirements (§112) →Patent eligibility (§101) →Inter partes review (after grant) →